Basic Information
ID: ALA5230068
Type: Functional
Description: Antiviral activity against RSV A2 infected in human HEp-2 cells assessed as reduction in viral plaque formation cells pretreated with compound for 15 mins followed by viral infection for 2.5 hrs and followed by incubation in CO2 incubator for 3 days by crystal violet staining based microscopic analysis
Organism: Respiratory syncytial virus
Strain: A2
Cell type: HEp-2
Activity Charts
Bioactivity
Activity Types for Assay ALA5230068
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 344.32 | 2.90 | 2.90 |
| 374.39 | 0.73 | 0.73 |
| 388.42 | 1.29 | 1.29 |
| 304.47 | 3.92 | 3.92 |
| 358.39 | 1.31 | 1.31 |
| 374.39 | 0.63 | 0.63 |
| 356.37 | 1.44 | 1.44 |